(8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one Struktur

(8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one

Bezeichnung:(8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one

CAS-Nr1235-15-0

Englisch Name:(8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one

CBNumberCB91236153

SummenformelC21H32O2

Molgewicht316.47758

MOL-Datei1235-15-0.mol

(8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one physikalisch-chemischer Eigenschaften

Schmelzpunkt	144-145°
Siedepunkt	459.5±45.0 °C(Predicted)
Dichte	1.09±0.1 g/cm3(Predicted)
Löslichkeit	soluble in Chloroform, Methanol
Aggregatzustand	Solid
pka	15.13±0.40(Predicted)
Farbe	Pale Beige

Sicherheit

Toxizität	LD50 orally in mice: >5010 mg/kg (Goldenthal)
DEA Controlled Substances	CSCN: 4000 CSA SCH: Schedule III NARC: No

(8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one Chemische Eigenschaften,Einsatz,Produktion Methoden

(8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Send Inquriy